Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study Evaluating Infliximab Treatment for Chinese Subjects With Moderate to Severe Plaque-type Psoriasis
This study has been completed.
Study NCT01177800   Information provided by Xian-Janssen Pharmaceutical Ltd.

First Received on August 5, 2010.   Last Updated on October 25, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
Placebo
Infliximab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Dermatologic Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Xian-Janssen Pharmaceutical Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services